logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
W

Wiesław Jerzy Cubała

Gdańsk Medical University

31H指数
287论文数
4.7K被引数
收录论文 101
发表时间
logo
Demographic Disparities in Clinical Trials of Xanomeline–Trospium for Schizophrenia: A Cross-Sectional Analysis of Data from ClinicalTrials.gov氯康唑-托司托铵治疗精神分裂症的临床试验中的人口统计学差异：对ClinicalTrials.gov数据的横断面分析
errEuropean Psychiatry
IF6.7
err2026-09-26
err0
errOAAI
errA. Kwaśny; D. Świeczkowski; A. Włodarczyk; A. Wilkowska; J. Słupski; W. J. Cubała
err分享
err收藏
Clinical correlates of non-responders to ketamine in terms of self-assessed life engagement among treatment-resistant depression patients治疗抵抗性抑郁症患者中，对氯胺酮无应答者的临床相关因素及其在自我评估生活参与度方面的表现
errJournal of Psychiatric Research
IF3.2
err2026-09-10
err0
PREAI
errMichał Walaszek; Wiesław Jerzy Cubała; Krzysztof Pastuszak; Zofia Kachlik
err分享
err收藏
331. Rapid antidepressant effects of inhaled GH001 in treatment-resistant depression: results from a phase 2b, double-blind, randomized controlled trial with 6-month follow-up331. 吸入用GH001在治疗抵抗性抑郁症中的快速抗抑郁效果：一项为期6个月随访的2b期、双盲、随机对照试验结果
errInternational Journal of Neuropsychopharmacology
IF3.7
err2026-09-09
err0
errOAAI
errW J Cubala; K Doolin; F Ryan; M E Thase; V Valcheva; B T Baune
err分享
err收藏
335. Safety and tolerability results from a phase 2b, double-blind trial with an open-label extension of GH001 in treatment-resistant depression335. GH001在治疗难治性抑郁症的2b期双盲试验及其开放标签扩展研究中的安全性与耐受性结果
errInternational Journal of Neuropsychopharmacology
IF3.7
err2026-09-09
err0
errOAAI
errB T Baune; T Benway; D Gregory; R MacIsaac; M E Thase; V Valcheva; W J Cubala
err分享
err收藏
Short-term ketamine interventions for depressive disorders: practical best-practice recommendations for psychiatrists using oral, subcutaneous, and nasal formulations抑郁症的短期氯胺酮干预：精神科医师使用口服、皮下和鼻喷制剂的最佳实践实用建议
errFrontiers in Psychiatry
IF3.2
err2026-09-04
err0
errOAAI
errAS Anita Słupska; WJ Wiesław Jerzy Cubała; DS Damian Swieczkowski; JS Joanna Szarmach; JS Jakub Słupski; AW Adam Włodarczyk
err分享
err收藏
The role of psychiatric nurses in nutritional care for treatment-resistant depression: a relapse-prevention perspective精神科护士在营养护理对治疗抵抗性抑郁症中的作用：从预防复发的角度
errFrontiers in Nutrition
IF5.1
err2026-09-04
err0
errOAAI
errAM Agnieszka Mechlińska; NS Natalia Sudoł; DP Dorota Pazda-Juda; WJ Wiesław Jerzy Cubała
err分享
err收藏
Neurodegenerative and Cognitive Consequences of Long COVID长新冠的神经退行性与认知后果
errInternational Journal of Molecular Sciences
IF4.9
err2026-08-02
err0
errOAAI
errLuiza Marek-Józefowicz; Alina Borkowska; Bogusław Nedoszytko; Wiesław Jerzy Cubała; Dorota Purzycka-Bohdan; Michał Bohdan
err分享
err收藏
Candidate Biomarkers of Bipolar Disorder Progression: Implications for Ketamine and Psychedelic Interventions双相障碍进展的候选生物标志物：对氯胺酮和致幻剂干预的启示
errMolecular Neurobiology
IF4.3
err2026-07-28
err0
PREAI
errAlina Wilkowska; Julia Nizgorska-Ohler; Wiesław Jerzy Cubała
err分享
err收藏
Patient-centred education for ketamine and esketamine therapies in mood disorders以患者为中心的教育在心境障碍中氯胺酮和右氯胺酮治疗中的应用
errTherapeutic Advances in Psychopharmacology
IF4
err2026-06-29
err0
PREAI
errZofia Kachlik; Wiesław Jerzy Cubała; Michał Walaszek
err分享
err收藏
Readability of informed consent forms from ClinicalTrials.gov in ketamine clinical trials for mental health conditions: a cross-sectional analysis精神健康条件下氯胺酮临床试验中知情同意书可读性分析：一项横断面研究
errTherapeutic Advances in Psychopharmacology
IF4
err2026-06-29
err0
PREAI
errDamian Swieczkowski; Aleksander Kwaśny; Wiesław Jerzy Cubała
err分享
err收藏
Beyond DSM Categories: Criteria for Biologically Valid Disease Axes in Psychiatry超越DSM分类：精神病学中生物学有效疾病轴的标准
errJournal of Clinical Medicine
IF2.9
err2026-06-23
err0
errOAAI
errLukasz Szarpak; Bernard Rybczynski; Michal Pruc; Bartosz W. Maj; Maciej Maslyk; Iwona Niewiadomska; Wieslaw J. Cubala
err分享
err收藏
Variability in AI-generated psychedelic definitions across major chatbots主流聊天机器人生成迷幻定义的差异性
errEuropean Neuropsychopharmacology
IF6.7
err2026-06-17
err0
PREAI
errZofia Kachlik; Wiesław Jerzy Cubała; Michał Walaszek
err分享
err收藏
Response to: Commentary on “Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study”针对“治疗难治性抑郁症患者长效右美托咪定鼻喷雾剂长期治疗：ESCAPE-LTE研究的结果”的评论
errEuropean Neuropsychopharmacology
IF6.7
err2026-06-05
err0
PREAI
errAndreas Reif; A. Elif Anıl Yağcıoğlu; Istvan Bitter; Jozefien Buyze; Richard Frey; Dong Jing Fu; Yordan Godinov; Lars Haggström; Yerkebulan Kambarov; René E. Nielsen; Albino J. Oliveira-Maia; Christian von Holt; Allan H. Young; Wiesław J. Cubała
err分享
err收藏
Treatment-emergent psychiatric adverse events in patient-reported outcomes during ketamine use for major depressive disorder: a retrospective analysis在氯胺酮治疗重度抑郁症期间患者报告结局中的治疗 emergent 精神科不良事件：一项回顾性分析
errPharmacological Reports
IF3.8
err2026-05-20
err0
errOAAI
errAleksander Kwaśny; Alina Wilkowska; Michał Pastuszak; Krzysztof Pastuszak; Wiesław Jerzy Cubała
err分享
err收藏
Regulatory context for protocol amendments and public reporting in psychedelic trials致幻药物临床试验中关于方案修改和公众报告的监管背景
errJournal of Clinical Epidemiology
IF5.2
err2026-05-04
err0
PREAI
errDamian Swieczkowski; Aleksander Kwaśny; Wiesław Jerzy Cubała
err分享
err收藏
Clinical correlates of anhedonia non-response to ketamine in treatment-resistant depression快感缺乏对氯胺酮无应答的临床相关因素在难治性抑郁症中的研究
errJournal of Affective Disorders
IF4.9
err2026-04-07
err0
PREAI
errMichał Walaszek; Wiesław Jerzy Cubała; Zofia Kachlik; Michał Pastuszak; Krzysztof Pastuszak; Aleksander Kwaśny
err分享
err收藏
Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study长期使用艾司氯胺酮鼻喷雾剂治疗难治性抑郁症患者：ESCAPE-LTE研究的成果
errEuropean Neuropsychopharmacology
IF6.7
err2026-02-27
err0
errOAAI
errA Reif; Yağcıoğlu AE Anıl; I Bitter; J Buyze; R Frey; Fu DJ; Y Godinov; L Haggström; Y Kambarov; RE Nielsen; AJ Oliveira-Maia; C von Holt; Young AH; WJ Cubała
err分享
err收藏
Anhedonia nonresponse to short-term ketamine administration for treatment-resistant bipolar depression
errTherapeutic Advances in Psychopharmacology
IF4
err2026-01-31
err0
PREAI
errZofia Kachlik; Wiesław Jerzy Cubała; Michał Walaszek; Michał Pastuszak; Krzysztof Pastuszak; Aleksander Kwaśny
err分享
err收藏
Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocols
errEuropean Neuropsychopharmacology
IF6.7
err2026-01-16
err0
PREAI
errDamian Swieczkowski; Aleksander Kwaśny; Krzysztof Sadko; Wiesław Jerzy Cubała
err分享
err收藏
Clozapine and treatment-resistant schizophrenia: evidence versus implementation氯氮平与难治性精神分裂症：证据与实践
errPsychopharmacology
IF3.3
err2026-01-06
err0
PREAI
errAlina Wilkowska; Wiesław Jerzy Cubała; Hélène Verdoux
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
M
Michael Berk
H 指数: 155 · 论文数: 2.2K
E
Eduard Vieta
H 指数: 153 · 论文数: 2.3K
P
Philip McGuire
H 指数: 152 · 论文数: 1.5K
R
Robert M. Post
H 指数: 126 · 论文数: 828
R
Roger S. McIntyre
H 指数: 125 · 论文数: 1.4K
查看更多